Ann: Publication on challenges of diagnosing respiratory disease, page-26

The study released June 6 2019 and the recently released study confirm the limitation in accurate respiratory diagnosis is Doctors misdiagnosing and potentially causing harm, poor stewardship of antibiotic use and poor treatment pathways.

Both studies indicate the cost of not using Resapp dx could be patient harm ...

Both studies indicate that Resapp dx is best practice in respiratory diagnosis in a face to face clinical setting.

Therefore I would conclude that not to uses Resapp dx as a inclusion with other clinical examinations and tests such as bloods, oxygen saturation, x-rays, and physical examination
in a clinical setting when diagnosing respiratory illness is nearing medical negligence.

As a stand alone respiratory diagnostic test these 2 studies confirm Resapp dx is best practice.

For telehealth the 2 studies indicate Resapp dx use during all respiratory consultations is now best practice.

MB